Stay updated on Nivo+Ipi +/- SBRT in Metastatic MCC Clinical Trial

Sign up to get notified when there's something new on the Nivo+Ipi +/- SBRT in Metastatic MCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivo+Ipi +/- SBRT in Metastatic MCC Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Added 'Cutaneous neuroendocrine carcinoma' as a related topic and a 'Genetic and Rare Diseases Information Center' resource under the Resources section.
    Difference
    0.2%
    Check dated 2026-04-02T15:11:01.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    Site version updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-18T22:51:44.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    Metadata revision updates were applied: a new Revision: v3.4.3 and recent date stamps (2026-03-11, 2026-09-19, 2026-02-26, 2026-02) were added. The previous Revision: v3.4.2 and older date stamps (e.g., 2025-12-22, 2025-12-04, 2025-12) were removed.
    Difference
    0.3%
    Check dated 2026-03-11T18:32:24.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    Added Moffitt Cancer Center Clinical Trials website and sponsor-related links, including a 'Helpful Links Provided by' section.
    Difference
    0.2%
    Check dated 2026-03-04T15:21:28.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Difference
    0.2%
    Check dated 2026-02-18T07:39:23.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    Revision: v3.4.2 has been added and the notice about a lapse in government funding (and Revision: v3.4.1) has been removed.
    Difference
    0.4%
    Check dated 2026-02-11T10:57:43.000Z thumbnail image

Stay in the know with updates to Nivo+Ipi +/- SBRT in Metastatic MCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivo+Ipi +/- SBRT in Metastatic MCC Clinical Trial page.